» Articles » PMID: 17213811

DNA Methylation and Histone Modification Regulate Silencing of Epithelial Cell Adhesion Molecule for Tumor Invasion and Progression

Overview
Journal Oncogene
Date 2007 Jan 11
PMID 17213811
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial cell adhesion molecule (Ep-CAM) is believed to have a critical role in carcinogenesis and cell proliferation. However, the association of Ep-CAM with cancer invasion and progression is less clear. We found that Ep-CAM was highly expressed on low-invasive cells compared with highly invasive cells. Forced expression of Ep-CAM decreased cancer invasiveness, and silencing Ep-CAM expression elevated cancer invasiveness. Ep-CAM expression was associated with promoter methylation. Treatment with a demethylating agent, and/or the histone deacetylase inhibitor reactivated Ep-CAM expression in Ep-CAM-negative cells and inhibited cancer invasiveness. Using a promoter-reporter construct, we demonstrated methylation of the promoter fragment drive Ep-CAM-silenced transcription. Additionally, silenced Ep-CAM gene in cancer cells was enriched for hypermethylated histone 3 lysine 9. When unmethylated and active, this promoter was associated with acetylated histone 3 lysine 9. Furthermore, we observed an increased association of Ep-CAM promoter with repression components as tumor invasiveness increased. In cancer tissues, Ep-CAM expression significantly correlated with tumor progression and associated with promoter methylation. Our data support the idea that modulation of Ep-CAM plays a pivotal role in tumor invasion and progression. Moreover, aberrant DNA methylation of Ep-CAM is implicated in enhancing invasive/metastatic proclivity of tumors.

Citing Articles

EpCAM Signaling in Oral Cancer Stem Cells: Implications for Metastasis, Tumorigenicity, and Therapeutic Strategies.

Chang C, Tsai C, Tsai F, Chu T, Hsu P, Kuo C Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996844 PMC: 11854592. DOI: 10.3390/cimb47020123.


Regulation of the Function and Expression of EpCAM.

Xiao D, Xiong M, Wang X, Lyu M, Sun H, Cui Y Biomedicines. 2024; 12(5).

PMID: 38791091 PMC: 11117676. DOI: 10.3390/biomedicines12051129.


EphrinA5 regulates cell motility by modulating Snhg15/DNA triplex-dependent targeting of DNMT1 to the Ncam1 promoter.

Bora Yildiz C, Kundu T, Gehrmann J, Koesling J, Ravaei A, Wolff P Epigenetics Chromatin. 2023; 16(1):42.

PMID: 37880732 PMC: 10601256. DOI: 10.1186/s13072-023-00516-4.


Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer.

Alwadi D, Felty Q, Yoo C, Roy D, Deoraj A Int J Mol Sci. 2023; 24(4).

PMID: 36834602 PMC: 9959535. DOI: 10.3390/ijms24043191.


Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside.

Liu Y, Wang Y, Sun S, Chen Z, Xiang S, Ding Z Exp Hematol Oncol. 2022; 11(1):97.

PMID: 36369033 PMC: 9650829. DOI: 10.1186/s40164-022-00352-4.